Marker Gene Technologies, Inc.
Records under this name other than the patents Marker Gene Technologies, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Showing 1 to 7 of 7 · Back to Marker Gene Technologies, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,677,115 | Enzyme substrates for visualizing acidic organelles Lapsed on the fee record Ended Jun 13, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 13, 2025 | From the USPTO record |
| US 8,460,862 | Enzyme substrates for visualizing acidic organelles Lapsed on the fee record Ended Jun 11, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 11, 2025 | From the USPTO record |
| US 9,610,358 | Targeted pharmacological chaperones Lapsed on the fee record Ended Apr 4, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 4, 2025 | From the USPTO record |
| US 10,543,282 | Targeted peptide conjugates Lapsed on the fee record Ended Jan 28, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jan 28, 2024 | From the USPTO record |
| US 7,723,502 | Modified Luciola cruciata luciferase gene and protein Lapsed on the fee record Ended May 25, 2022 · From the USPTO record | Lapsed on the fee record | Ended May 25, 2022 | From the USPTO record |
| US 8,716,558 | Method of altering glycosylation of proteins in response to nojirimycin glucuronide in a plant cell expressing glucuronidase Lapsed on the fee record Ended May 6, 2022 · From the USPTO record | Lapsed on the fee record | Ended May 6, 2022 | From the USPTO record |
| US 6,656,917 | Compositions and methods for targeted enzymatic release of cell regulatory compounds Lapsed on the fee record Ended Dec 2, 2015 · From the USPTO record | Lapsed on the fee record | Ended Dec 2, 2015 | From the USPTO record |